S. Umamatheswari, S. Kabilan / Journal of Molecular Structure 938 (2009) 142–149
149
Table 4
References
Geometric parameters of compound 3.
[
1] C.L. Stevens, P. Blumbergs, D.H. Otterbach, J.L. Stronming, M. Matsuhashi, D.N.
Dietzler, J. Am. Chem. Soc. 86 (1964) 2937;
Geometric parameters
XRD
PM3 calculation
Bond length (Å)
C(6)AC(7)
C(6)AC(11)
C(21)AO(3)
C(3)AS(1)
C.L. Stevens, P. Blumbergs, F.A. Daniher, J. Am. Chem. Soc. 85 (1963) 1552.
1.375(4)
1.366(3)
1.213(3)
1.852(2)
1.480(3)
1.263(3)
1.342
1.334
1.268
2.000
1.537
1.303
[2] N.D. Heindal, J.R. Reid, J. Heterocycl. Chem. 17 (1980) 1087.
[3] R.H. Bradbury, J.E. Revett, J. Med. Chem. 34 (1991) 151;
R.H. Bradbury, Heterocycles 32 (1991) 449.
4] M. Dohaz, S. Rekas, J. Acta Pol. Pharm. 52 (1995) 35;
S.G. Komurcu, S. Rollas, Z. Yilmaz, A. Ceuikbas, Drug Metab. Drug Interact. 12
[
C(3)AN(2)
C(18)AN(1)
(
1995) 161.
[
5] H.K. Shukla, N.C. Desai, R.R. Astik, K.A. Thaker, J. Indian Chem. Soc. (1984) 168.
Bond angle (°)
[6] N.C. Desai, H.K. Shukla, B.P. Parekh, K.A. Thaker, J. Indian Chem. Soc. (1984)
455.
[7] K. Pan, M.K. Scott, D.H.S. Lee, L.J. Fitzpatric, J.J. Crooke, R.A. Rivero, D.I.
Rosenthal, A.H. Vaidya, B. Zhao, A.B. Reiz, Bioorg. Med. Chem. 11 (2003) 185.
C(21)AN(2)AN(1)
C(11)AC(6)AC(7)
C(7)AC(6)AC(5)
C(21)AN(2)AN(1)
C(18)AN(1)AN(2)
N(1)AN(2)AC(3)
C(21)AN(2)AN(1)
C(18)AN(1)AN(2)
N(1)AC(18)AN(3)
C(19)AN(3)AC(18)
O(2)AC(19)AN(3)
111.26(17)
117.8(2)
122.2(2)
119.15(18)
111.26(17)
117.39(17)
119.15(18)
111.26(17)
119.48(19)
126.0(2)
112.88
117.21
121.12
120.70
120.02
122.67
120.09
112.88
118.89
124.17
120.69
[
8] K.Y. Jung, S.K. Kim, Z.G. Gao, A.S. Gross, N. Melman, K.A. Jacobson, Y.C. Kim,
Bioorg. Med. Chem. 12 (2004) 613.
[
9] A. Foroumadi, A. Asadipour, M. Mirzaei, J. Karimi, S. Emami, IL Farmaco 57
(
2002) 765.
[
[
[
10] A.R. Jalilian, S. Sattari, M. Bineshmarvasti, M. Daneshtalab, A. Shafiee, IL
Farmaco 58 (2002) 63.
11] R. Leung-Toung, J. Wodzinska, W. Li, J. Lowrie, R. Kukreja, D. Desilets, K.
Karimian, T.F. Tam, Bioorg. Med. Chem. 11 (2003) 5529.
12] (a) B. Holmberg, Arkiv. Kemi 7 (1954) 517;
121.1(3)
(
b) J. Sandstron, Adv. Heterocycl. 9 (1968) 165.
Torsion angle (°)
[
[
[
[
[
13] D. Evans, D.R. Taylor, J. Chem. Soc. Chem. Commun. (1982) 188.
14] M.A. Martins Alho, N.B. D’Accorso, J. Heterocycl. Chem. 34 (1997) 1415.
15] S. Andreae, E. Schmitz, H. Seeboth, J. f. prakt. Chem. 328 (1986) 205.
16] L. Somogyi, Tetrahedron 47 (1991) 9305.
C(1)AC12)AC(17)AC(16)
C(5)AO(1)AC(1)AC(12)
C(22)AC(21)AN(2)AN(1)
C(22)AC(21)AN(2)AC(3)
O(2)AC(19)AN(3)AC(18)
C(19)AN(3)AC(18)AS(1)
C(19)AN(3)AC(18)AN(1)
H(2a)AC(2)AC(3)AS
177.9(3)
À179.0(3)
À3.3(4)
178.07
À178.94
À2.26
À177.1(3)
À1.25(3)
6.39(3)
À174.90
176.01
À3.2
17] S. Kubota, Y. Ueda, K. Fujikane, K. Toyooka, M. Shibuya, J. Org. Chem. 45 (1980)
1
473.
[
18] C. Ramalingan, S. Balasubramanian, S. Kabilan, Synth. Commun. 34 (6) (2004)
174.47(2)
À173.33
À52.80
172.10
À175.23
À57.43
À62.56
À174.99
1105;
C. Ramalingan, S. Balasubramanian, S. Kabilan, Heterocycl. Commun. 10 (2/3)
(2004) 187;
C. Ramalingan, S. Balasubramanian, S. Kabilan, Synth. Commun. 33 (9) (2003)
443;
S. Balasubramanian, C. Ramalingan, S. Kabilan, Indian. J. Chem. 41B (2002)
H(2b)AC(2)AC(3)AS
H(2a)AC(2)AC(3)AN(2)
C(1)AO(1)AC(5)AC(6)
À58.93
À172.26
2
402;
S. Balasubramanian, C. Ramalingan, S. Kabilan, Synth. Commun. 33 (17) (2003)
979;
C. Ramalingan, S. Balasubramanian, S. Kabilan, M. Vasudevan, Med. Chem. Res.
2 (1) (2003) 26;
2
4
. Conclusion
Conformation of title compound was carried out using NMR
1
C. Ramalingan, S. Balasubramanian, S. Kabilan, M. Vasudevan, Eur. J. Med.
Chem. 39 (2004) 527;
C. Ramalingan, S. Balasubramanian, S. Kabilan, M. Vasudevan, Med. Chem. Res.
spectral data, X-ray diffraction. The semiempirical molecular orbi-
tal calculation (PM3) also carried out to investigate the conforma-
tional preference of N-acetyl group of 1,3,4-thiadiazoline moiety.
The results show that the title compound exist in chair conforma-
tion with equatorial orientations of two phenyl groups at C-2, C-6,
methyl group at C-3 carbons and N-acetyl group of thiadiazoline
moiety. The results obtained from NMR spectra are in good agree-
ment with those from X-ray crystallography and MOPAC (PM3)
calculation.
12 (1) (2003) 41;
S. Balasubramanian, C. Ramalingan, G. Aridoss, P. Parthiban, S. Kabilan, Med.
Chem. Res. 13 (5) (2004) 297;
S. Balasubramanian, C. Ramalingan, G. Aridoss, S. Kabilan, Eur. J. Med. Chem.
4
0 (2005) 694;
S. Balasubramanian, G. Aridoss, P. Parthiiban, S. Kabilan, Biol. Pharm. Bull. 29
1) (2006) 125;
G. Aridoss, S. Balasubramanian, P. Parthiban, S. Kabilan, Eur. J. Med. Chem. 42
2007) 860.
[19] J.J.P. Stewatt, MOPAC 2000 V 1.3 User’s Manual, Fujitsu Limited, 2000.
(
(
[
20] G.M. Sheldrick, SHELXS-97 Program for the Solution of Crystal Structures,
University of Gottingen, Gottingen, Germany, 1997.
Acknowledgements
[
21] A.L. Spek, PLATON, in:
A Multipurpose Crystallographic Tool, Utrecht
University, Utrecht, The Netherlands, 1999.
22] F.R. Japp, W. Maitland, J. Chem. Soc. 85 (1904) 1473.
23] S. Umamatheswari, J. Jayapratha, S. Kabilan, Eur. J. Med. Chem., submitted for
publication.
[24] K. Ramalingam, K.D. Berlin, J. Org. Chem. 44 (1979) 471;
V. Baliah, G. Mangalam, Indian J. Chem. 16B (1978) 213.
25] P.S. Kalsi, Stereochemistry: Conformation and Mechanism, New Age
International, New Delhi, 1997. p. 236.
26] T.R. Sarangarajan, K. Panchanatheswaran, K. Thanikachalam, R. Jeyaraman,
Acta Crystallogr. E 58 (2002) o1053–o1054.
[
[
Authors are thankful to Professor K. Pandiarajan, Head, Depart-
ment of Chemistry, Annamalai University for the facilities pro-
vided. Authors are thankful Council of Scientific and Industrial
Research, New Delhi, India for financial support. The authors would
like to acknowledge NMR research center, IISc-Bangalore and SAIF,
IIT-Madras, respectively, for recording NMR and single crystal XRD.
The authors also acknowledge Dr. M. Ramalingam, Scientist, Prist
University, Thanjavur, for PM3 calculations.
[
[